A Multicenter, Open-Label, First-In-Human, Multiple Expansion Cohort, Phase 1/2 Study to Evaluate the Safety and Efficacy of DR-01 in Adult Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas.

A phase III, randomized, 2-arm, open-label, multicenter, stratified study of soquelitinib versus physician's choice standard of care (SOC) treatment (selected single agents) in participants with relapsed/refractory (R/R) peripheral T-cell lymphoma not otherwise specified (PTCL- NOS), follicular helper T-cell lymphomas (FHTCLs), or systemic anaplastic large-cell lymphoma (sALCL).

A phase II, open-label, multicenter study of MB-105 in patients with CD5 positive (CD5+) relapsed / refractory T-cell lymphoma (r/r TCL).

The cutaneous lymphoma clinic is a multidisciplinary clinic comprised of dermatologist (Dr Steven Chen), radiation oncologist (Dr Chirayu Patel) and lymphoma physicians (Drs Jeffrey Barnes and Jain). This is a specialty one stop clinic in which we offer comprehensive and integrated care for patients with cutaneous lymphomas ranging from diagnosis to treatments. This clinic is located within the lymphoma clinic in the Yawkey Building at 32 Fruit Street, Massachusetts General Hospital. Contact: To schedule an appointment,
Please call: 617.724.4000.